These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19862498)

  • 1. The economic costs of diabetes in developing countries: some concerns and recommendations.
    Khuwaja AK; Khowaja LA; Cosgrove P
    Diabetologia; 2010 Feb; 53(2):389-90; author reply 391-2. PubMed ID: 19862498
    [No Abstract]   [Full Text] [Related]  

  • 2. Health and economic burden of diabetes in Bangladesh: Priorities for attention and control.
    Sarker AR; Sultana M
    J Diabetes; 2017 Dec; 9(12):1118-1119. PubMed ID: 28749030
    [No Abstract]   [Full Text] [Related]  

  • 3. How should developing countries manage diabetes?
    Narayan KM; Zhang P; Williams D; Engelgau M; Imperatore G; Kanaya A; Ramachandran A
    CMAJ; 2006 Sep; 175(7):733. PubMed ID: 17001048
    [No Abstract]   [Full Text] [Related]  

  • 4. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
    Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes.
    Yach D; Stuckler D; Brownell KD
    Nat Med; 2006 Jan; 12(1):62-6. PubMed ID: 16397571
    [No Abstract]   [Full Text] [Related]  

  • 6. Burden of diabetes in Iran: how will it be affected by lifting of the economic sanctions?
    Larijani B
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):810-1. PubMed ID: 27527914
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
    Arredondo A; Azar A; Recamán AL
    Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes in numbers.
    Scully T
    Nature; 2012 May; 485(7398):S2-3. PubMed ID: 22616094
    [No Abstract]   [Full Text] [Related]  

  • 9. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
    Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A
    PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in diabetes: sounding the alarm.
    Krug EG
    Lancet; 2016 Apr; 387(10027):1485-1486. PubMed ID: 27061675
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of health systems on diabetes care in low and lower middle income countries.
    Beran D
    Curr Diab Rep; 2015 Apr; 15(4):20. PubMed ID: 25721248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The socioeconomics of diabetes from a developing country: a population based cost of illness study.
    Tharkar S; Devarajan A; Kumpatla S; Viswanathan V
    Diabetes Res Clin Pract; 2010 Sep; 89(3):334-40. PubMed ID: 20538363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of diabetes care in out-patient clinics of Karachi, Pakistan.
    Khowaja LA; Khuwaja AK; Cosgrove P
    BMC Health Serv Res; 2007 Nov; 7():189. PubMed ID: 18028552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing diabetes mellitus in developing countries.
    Echouffo-Tcheugui JB; Dagogo-Jack S
    Nat Rev Endocrinol; 2012 Sep; 8(9):557-62. PubMed ID: 22488646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes--a global threat.
    Lancet; 2009 May; 373(9677):1735. PubMed ID: 19465209
    [No Abstract]   [Full Text] [Related]  

  • 16. Syndemics at play: chronic kidney disease, diabetes and COVID-19 in Pakistan.
    Ali I
    Ann Med; 2021 Dec; 53(1):581-586. PubMed ID: 33825598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the economic and social consequences of CVDs and diabetes in India and Pakistan.
    Govender VM; Ghaffar A; Nishtar S
    Biosci Trends; 2007 Dec; 1(3):121-7. PubMed ID: 20103881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
    Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
    BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National registries as a catalyst to development of diabetes care in low-income and middle-income countries.
    Jackson-Morris AM; Sembajwe R; Nugent R
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):199-200. PubMed ID: 33577750
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India.
    Singh AK; Misra A
    Diabetes Metab Syndr; 2020; 14(6):1625-1630. PubMed ID: 32891011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.